June 3, 2022 01:27 PM EDT
Pharma

CDC treats first mon­key­pox pa­tient with SIGA's small­pox an­tivi­ral via ex­pand­ed ac­cess

Zachary Brennan

Senior Editor

The CDC said Fri­day that one mon­key­pox pa­tient in the US so far has been treat­ed with SIGA Tech­nolo­gies’ tecovir­i­mat, known com­mer­cial­ly as TPOXX, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

A service from the Financial Times